list of fda approved glp-1 receptor agonists FDA-Approved Dosages and Indications for and Dual GIP/GLP-1 GLP-1 Receptor Agonists List: Complete
Description
GLP-1 RAs may also reduce inflammation both indirectly through weight loss and directly through activation of GLP-1 activation on T cells, which may explain the lower rates of cardiorenal disease in people using these drugs [48]

Common adverse effectsnausea, vomiting, diarrheatypically diminish with gradual dose titration

A similar increased risk for heart failure was also observed for alogliptin (3.9% vs 3.3% for placebo)

It is biology

Carcinogenicity No information on the carcinogenic effects of gila monster venom could be found

Applications of Connectivity Map in drug discovery and development
